KR20240169690A - 거대고리 펩티드 항생제의 결정질 형태 - Google Patents

거대고리 펩티드 항생제의 결정질 형태 Download PDF

Info

Publication number
KR20240169690A
KR20240169690A KR1020247036516A KR20247036516A KR20240169690A KR 20240169690 A KR20240169690 A KR 20240169690A KR 1020247036516 A KR1020247036516 A KR 1020247036516A KR 20247036516 A KR20247036516 A KR 20247036516A KR 20240169690 A KR20240169690 A KR 20240169690A
Authority
KR
South Korea
Prior art keywords
theta
wavenumbers
xrpd
atr
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247036516A
Other languages
English (en)
Korean (ko)
Inventor
랄프 디오돈
안드레 에글리
데니스 디모 엔켈만
마이클 도미니크 린데머
발렌틴 안드레아스 스타델만
Original Assignee
에프. 호프만-라 로슈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 호프만-라 로슈 아게 filed Critical 에프. 호프만-라 로슈 아게
Publication of KR20240169690A publication Critical patent/KR20240169690A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020247036516A 2022-04-07 2023-04-05 거대고리 펩티드 항생제의 결정질 형태 Pending KR20240169690A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22167057.3 2022-04-07
EP22167057 2022-04-07
PCT/EP2023/058906 WO2023194418A1 (en) 2022-04-07 2023-04-05 Crystalline forms of a macrocyclic peptide antibiotic

Publications (1)

Publication Number Publication Date
KR20240169690A true KR20240169690A (ko) 2024-12-03

Family

ID=81448543

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247036516A Pending KR20240169690A (ko) 2022-04-07 2023-04-05 거대고리 펩티드 항생제의 결정질 형태

Country Status (10)

Country Link
EP (1) EP4504749A1 (enExample)
JP (1) JP2025511869A (enExample)
KR (1) KR20240169690A (enExample)
CN (1) CN118974073A (enExample)
AU (1) AU2023250008A1 (enExample)
CA (1) CA3255726A1 (enExample)
IL (1) IL315686A (enExample)
MX (1) MX2024012228A (enExample)
TW (1) TW202404991A (enExample)
WO (1) WO2023194418A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026154152A1 (en) * 2025-01-20 2026-07-23 F. Hoffmann-La Roche Ag Pharmaceutical compositions comprising an antibiotic macrocyclic peptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11819532B2 (en) 2018-04-23 2023-11-21 Hoffmann-La Roche Inc. Peptide macrocycles against Acinetobacter baumannii

Also Published As

Publication number Publication date
CN118974073A (zh) 2024-11-15
CA3255726A1 (en) 2023-10-12
EP4504749A1 (en) 2025-02-12
IL315686A (en) 2024-11-01
MX2024012228A (es) 2024-11-08
WO2023194418A1 (en) 2023-10-12
TW202404991A (zh) 2024-02-01
AU2023250008A1 (en) 2024-10-03
JP2025511869A (ja) 2025-04-16

Similar Documents

Publication Publication Date Title
AU2009245817B2 (en) Organic compounds
JP2020528399A (ja) 抗生物質耐性ブレーカー
CN107056813B (zh) 德罗格韦钠盐的晶型及其制备方法
AU2023250008A1 (en) Crystalline forms of a macrocyclic peptide antibiotic
HK40114674A (en) Crystalline forms of a macrocyclic peptide antibiotic
KR102205843B1 (ko) 9-아미노메틸 치환된 테트라사이클린 화합물의 결정형 및 그것의 제조 방법
AU2010277947B2 (en) R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl- 6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
CA2929199C (en) Crystalline beta-lactamase inhibitor
HK1149754A (en) Process for purifying staurosporine
JPH04210691A (ja) ３‐（‐４‐シンナミル‐１‐ピペラジニル）‐イミノメチルリファマイシンｓｖの非溶媒和結晶形‘ａ’およびその製造方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20241031

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application